Navigation Links
Grifols Biomat USA Opens New Plasma Donor Center in Lincoln
Date:7/31/2008

New Center Provides Lincoln Citizens the Opportunity to Give the Gift of

Life

LINCOLN, Neb., July 31 /PRNewswire/ -- Today, Grifols Biomat USA celebrates the grand opening of a new plasma donor center in Lincoln, Nebraska. The Lincoln center located on 2002 N Street is one of 60 Biomat USA center to be opened in the United States and the first in Nebraska. The plasma donated at the Lincoln center is then used by Biomat USA's parent company Grifols to produce life-saving medicines.

Plasma is part of the blood that contains proteins and antibodies that are needed to fight infection and help stop bleeding, among other things. In the U.S. alone, it is estimated that over one hundred thousand people receive medicines made from human plasma each year. Plasma collected at Biomat USA plasma centers is used to produce these therapies such as: intravenous immune globulin (IVIG) to treat primary immunodeficiency; blood clotting factors to treat hemophilia and other bleeding disorders; and albumin, used for shock, trauma, and burns. For these conditions and others, regular and life-long treatment with a plasma therapy is the only treatment option.

Marcia Boyle, Immune Deficiency Foundation President, Founder and mother of a son with a primary immunodeficiency remarked "Since the production of IVIG, and other plasma therapies, begins with the donation of human plasma, Lincoln's donors play a vital role in maintaining an adequate supply of plasma needed to produce these life-saving plasma treatments. Because of these donors, countless people, such as my son, who depend on IVIG, and other plasma therapies, can live healthy and productive lives."

Not only does each Biomat USA Center serve a global mission of being an integral part in the production of life-saving medicines but each donor center also serves locally by providing vital economic and community service contributions. The Lincoln Center currently employs 32 local citizens and plans to hire an additional thirteen as the center grows. In addition, the Center will contribute close to $1.6 million annually to the Lincoln economy and most importantly has the capacity to process 1500 donors a week.

"The demand for plasma therapies has been increasing over the last few years and maintaining a readily available supply of plasma is essential to assuring continuous production of these much needed life-saving medicines," said Shinji Wada, President of Biomat USA. "Our strategy for opening new centers is focused on securing a stable supply of plasma in order to meet the needs of the expanding market," Wada said.

About Grifols Biomat USA:

Grifols Biomat USA is part of a large a network of plasma collection centers owned and operated by Grifols, a global healthcare company headquartered in Barcelona, Spain. Today, Grifols' plasma therapies are used to treat patients in more than 90 countries around the world. More information about Grifols Biomat USA and Grifols can be found at http://www.grifols.com.


'/>"/>
SOURCE Grifols Biomat USA
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Rutgers biomaterial debuts in clinical trials of new stent
2. Clear Catheter Systems Completes $600-Million Financing, Opens Cleveland Office
3. Eighth Dr. Siegal's COOKIE DIET Retail Location Opens August 1st at Tysons Corner Center Near Washington, DC
4. Abt Associates Opens Atlanta Office
5. CRH Medical Corporation opens center in New Orleans, Louisiana
6. Ricochet Public Relations Opens Washington, D.C. Office
7. Sport Chalet Opens Store in West Los Angeles
8. Londons Royal Brompton Hospital Opens New Electrophysiology Lab With State of the Art Magnetic Technology to Treat Arrhythmias
9. CRH Medical Corporation opens Center in San Diego California
10. Abbott Opens New State-of-the-Art R&D Facility to Help Bring Medicines to Patients Faster
11. Go Vertical Chicago 2008 Sears Tower Stair Climb Registration Opens June 10
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... 2017 , ... "TransFlare 4K Mystique comes with 44 colorful mysterious transitions that ... Christina Austin - CEO of Pixel Film Studios. , TransFlare 4K Mystique contains ... lens flare and light leak transitions have a very high-dynamic range for super smooth ...
(Date:1/20/2017)... ... ... a fine examination of how God handles sin, including how to let go of ... who, for over ten long years has been waiting to release this powerful insight about ... has been serving the Lord for over twenty years, and he has been preaching and ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “The Land of ... attention to the issue of world hunger, and shares the simple and achievable answer. ... devoted husband and member of the Fairview Missionary Church in Angola, Indiana where he ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... and facility enhancement of their 503A compounding pharmacy located in Ocala, Florida. ... of physicians and patients throughout the United States for high-quality human anti-aging ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... has recently unveiled impressive transportable capabilities with their iMedHD2™ Portable Teleultrasound ... extension to RMT technology that delivers HD, dynamic, streaming ultrasound images and video ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 ViewRay, Inc. (Nasdaq: ... federal institution supporting research in Germany ... patient treatments at the University Clinic Heidelberg as part ... The MRIdian Linac program will be headed by Medical ... heads radiation oncology at the German Cancer Research Center ...
(Date:1/19/2017)... ALTO, Calif. , Jan. 19, 2017   ... research, is excited to announce that the first ... Cancer Biology  (RP:CB) have been published in eLife ... this project represents the first practical evaluation of ... result in reproducible studies. Unlike other assessments of ...
(Date:1/19/2017)... January 19, 2017 New ... to Address Motor Symptoms and Motor Complications in ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) C ... European Neurological Review,2016;11(Suppl. 2): 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late ...
Breaking Medicine Technology: